Rights and permissions
About this article
Cite this article
Lenograstim + chemotherapy for small cell lung cancer: cost effectiveness “finely balanced”. Inpharma Wkly. 1542, 4 (2006). https://doi.org/10.2165/00128413-200615420-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615420-00007